Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging

[1]  A. Kjaer,et al.  Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response , 2020, BMC Cancer.

[2]  N. Obuchowski,et al.  Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trials , 2018, Journal of magnetic resonance imaging : JMRI.

[3]  K. Winter,et al.  Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma , 2018, Oncotarget.

[4]  K. Winter,et al.  Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma , 2018, Oncotarget.

[5]  Alexey Surov,et al.  Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis , 2017, Oncotarget.

[6]  Ying Sun,et al.  Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma , 2017, Journal of Cancer.

[7]  Yu Xiao-ping,et al.  Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.

[8]  D. Collins,et al.  Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions , 2015, European Radiology.

[9]  Weibo Chen,et al.  Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast‐enhanced 3.0 T MRI , 2015, Journal of magnetic resonance imaging : JMRI.

[10]  Yun-bin Chen,et al.  Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. , 2014, Magnetic resonance imaging.

[11]  Jing Yuan,et al.  Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck. , 2012, Quantitative imaging in medicine and surgery.

[12]  A. W. Simonetti,et al.  Pharmacokinetic analysis based on dynamic contrast‐enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[13]  S. Yang,et al.  Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation. , 2011, International journal of radiation oncology, biology, physics.

[14]  Chaosu Hu,et al.  Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  David Atkinson,et al.  Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI , 2008, Physics in medicine and biology.

[16]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[17]  Anne W. M. Lee.  Current Management Strategies for Non-Metastatic Nasopharyngeal Cancer , 2006 .

[18]  T. Bezabeh,et al.  Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. , 2005, AJNR. American journal of neuroradiology.

[19]  Haruhiro Inoue,et al.  Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research. , 2002, The Lancet. Oncology.

[20]  A. Harris,et al.  Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  M V Knopp,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.

[22]  J. Sham,et al.  The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma , 1999, Cancer.

[23]  S. Fox,et al.  TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.

[24]  A. Boss,et al.  Quantitative imaging. , 2015, Investigative radiology.

[25]  Massimo Filippi,et al.  Diffusion-Weighted MRI , 2003 .

[26]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[27]  S. Leung,et al.  Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. , 1994, The British journal of radiology.

[28]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[29]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[30]  Physics and Imaging in Radiation Oncology , 2022 .